News Center

News Center

Zhejiang Kisun Pharmaceutical’s Imatinib Tablets Successfully Shipped to Europe for the First Time

The first batch of imatinib tablets produced by Zhejiang Qizheng Pharmaceutical and destined for Europe was officially dispatched on November 19th.

2025/12/01


【Craftsmanship in Partnership, Guardians of Health】— European-Quality Imatinib, Delivering a High-Quality Imatinib Product Series

Zhejiang Kisun Pharma rigorously fulfills its pharmaceutical mission. In partnership with STADA, Kisun is making high-quality international medicines readily accessible, injecting solid strength into life and health.

2025/10/01


Groundbreaking Approval: Taizhou Bay New District Secures Its First Drug Registration Certificate

Recently, the biopharmaceutical industry development of Taizhou Bay New District took a historic step forward—Zhejiang Kisun Pharmaceutical Co., Ltd.

2025/04/08


Director Mei Shimiao Conducts "Four Majors: Major Visits, Major Research, Major Services, and Major Solving" Activity to Boost a Strong Start in the First Quarter

On January 28th, the first working day after the Chinese New Year, Mei Shimiao, Director of the Taizhou Bay New District Management Committee

2023/02/03


< 1 >

Product Inquiry

*Note: Please provide the information accurately, and we will contact you as soon as possible.

Submit